The use of platelet-rich plasma to treat chronic tendinopathies: A technical analysis

References

• Kaux J-F, Degrave N, Crielaard J-M. Platelet rich plasma: traitement des tendinopathies chroniques? Revue de la littérature. J Traumatol Sport 2007;24(2):99–102.
   Google Scholar
• Kaux JF, Croisier JL, Forthomme B, Crielaard JM. Nouveaux traitements conservateurs des tendinopathies chroniques. Rev Med Liege 2015;70(10):507–510.
   PubMedGoogle Scholar
• Mejia HA, Bradley JP. The effects of platelet-rich plasma on muscle: basic science and clinical application. YOTSM. Elsevier Inc. 2011;19(3):149–153.
   Google Scholar
• Kaux JF, Drion P, Croisier JL, Crielaard JM. Tendinopathies and platelet-rich plasma (PRP): from pre-clinical experiments to therapeutic use. J Stem Cells Regener Med 2015;11(1):P7–P17.
   PubMed Web of Science ®Google Scholar
• Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sport Med 2009;37(11):2259–2272.
   PubMed Web of Science ®Google Scholar
• Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 1998;85(6):638–646.
   PubMed Web of Science ®Google Scholar
• Rožman P, Bolta Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerologica Alpina, Pannonica Adriat 2007;16(4):156–165.
   PubMedGoogle Scholar
• Kaux J-F, Crielaard J-M. Tendon et tendinopathie. J Traumatol Sport 2014;31(4):235–240.
   Google Scholar
• Sancerne A, Kaux JF. Revue épidémiologique des tendinopathies les plus fréquentes. J Traumatol Sport 2015;32(4):223–228.
   Google Scholar
• Smets F, Croisier J-L, Forthomme B, Crielaard J-M, Kaux J-F. Applications cliniques du plasma riche en plaquettes (PRP) dans les lésions tendineuses: revue de la littérature. Sci Sports 2012;27(3):141–153.
   Web of Science ®Google Scholar
• Kaux J-F, Crielaard J-M. Tendinopathies and platelet-rich plasma: clinical applications. A review of the literature | [Tendinopathies et plasma riche en plaquettes (PRP) : Applications cliniques. Revue de la littérature]. J Traumatol Sport 2012;29(3):174–178.
   Google Scholar
• Kaux J-F, Drion P, Croisier J-L, Crielaard J-M. Plasma riche en plaquettes pour le traitement de lésions tendineuses. J Readaptation Med 2015;35(3):333, 181–191.
   Google Scholar
• Kaux J-F, Le Goff C, Renouf J, Gothot A, Crielaard J-M, et al. Comparison of the platelet concentrations obtained in platelet-rich plasma (PRP) between the GPS™ II and GPS™ III systems. Pathol Biol 2011;59(5):275–277.
   PubMed Web of Science ®Google Scholar
• Kaux J-F, Le Goff C, Seidel L, Albert A, Crielaard J-M, et al. Étude comparative de cinq techniques de préparation plaquettaire (platelet-rich plasma). Pathol Biol 2011;59(3):157–160.
   PubMed Web of Science ®Google Scholar
• Marques LF, Stessuk T, Camargo IC, Sabeh Junior N, Dos Santos L, Ribeiro-Paes JT. Platelet-rich plasma (PRP): methodological aspects and clinical applications. Platelets 2014;26(2):101–113.
   PubMed Web of Science ®Google Scholar
• Kaux J-F, Bouvard M, Lecut C, Sanchez M, Crielaard J-M, et al. Reflections about the optimisation of the treatment of tendinopathies with PRP. Muscles, Ligaments and Tendons Journal 2015;5(1):1–4.
   PubMedGoogle Scholar
• Peerbooms JC, Van Laar W, Faber F, Schuller HM, Van Der Hoeven H, Gosens T. Use of platelet rich plasma to treat plantar fasciitis: design of a multi centre randomized controlled trial. BMC Musculoskelet Disord 2010;11:69.
   PubMed Web of Science ®Google Scholar
• Galanis V, Monga F, Nalmpantis N, Diamantidus E, Panagiotidis D, Mitsitskas T. The use of platelet-rich plasma in severe chronic lateral epicondylitis of the elbow. J Bone Jt Surg Br 2011;93:15123.
   Google Scholar
• Hechtman KS, Uribe JW, Botto-vanDemden A, Kiebzak GM. Platelet-rich plasma injection reduces pain in patients with recalcitrant epicondylitis. Orthopedics 2011;34(2):92.
   PubMedGoogle Scholar
• Creaney L, Wallace A, Curtis M, Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med 2011;45(12):966–971.
   PubMed Web of Science ®Google Scholar
• Thanasas C, Papadimitriou G, Charalambidis C, Paraskevopoulos I, Papanikolaou A. platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. Am J Sports Med 2011;39(10):2130–2134.
   PubMed Web of Science ®Google Scholar
• Gosens T, Peerbooms JC, Van Laar W, Den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis. Am J Sports Med 2011;39(6):1200–1208.
   PubMed Web of Science ®Google Scholar
• Omar AS, Ibrahim ME, Ahmed AS, Said M, Author A, et al. Local injection of autologous platelet rich plasma and corticosteroid in treatment of lateral epicondylitis and plantar fasciitis: randomized clinical trial. Egypt Rheumatol Egypt Soc Jt Dis Arthritis 2012;34(2):43–49.
   Google Scholar
• Krogh TP, Fredberg U, Stengaard-Pedersen K, Christensen R, Jensen P, Ellingsen T. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial. Am J Sports Med 2013;41(3):625–635.
   PubMed Web of Science ®Google Scholar
• Martin JI, Merino J, Atilano L, Areizaga LM, Gomez-Fernandez MC, Burgos-Alonso N, et al. Platelet-rich plasma (PRP) in chronic epicondylitis: study protocol for a randomized controlled trial. Trials 2013;14:410.
   Google Scholar
• Mishra AK, Skrepnik NV, Edwards SG, Jones GL, Sampson S, Vermillion D, et al. Platelet-rich plasma significantly improves clinical outcomes in patients with chronic tennis elbow: a double-blind, prospective, multicenter, controlled trial of 230 patients. Am J Sports Med 2014;42(2):463–471.
   PubMed Web of Science ®Google Scholar
• Raeissadat SA, Rayegani SM, Hassanabadi H, Rahimi R, Sedighipour L, Rostami K. Is Platelet-rich plasma superior to whole blood in the management of chronic tennis elbow: one year randomized clinical trial. BMC Sports Sci Med Rehabil 2014;6(1):12.
   PubMedGoogle Scholar
• Tonk G, Kumar A, Gupta A. Platelet rich plasma versus laser therapy in lateral epicondylitis of elbow. Indian J Orthop 2014;48(4):390–392.
   PubMed Web of Science ®Google Scholar
• Chiavaras MM, Jacobson J, Carlos R, Maida E, Bentley T, Simunovic N, et al. IMpact of platelet rich plasma over alternative therapies in patients with lateral epicondylitis (IMPROVE): protocol for a multicenter randomized controlled study: a multicenter, randomized trial comparing autologous platelet-rich plasma, autologous whole. Acad Radiol. Elsevier Ltd. 2014;21(9):1144–1155.
   PubMed Web of Science ®Google Scholar
• Ford RD, Schmitt WP, Lineberry K, Luce P. A retrospective comparison of the management of recalcitrant lateral elbow tendinosis: platelet-rich plasma injections versus surgery. Hand 2014;285–291.
   Google Scholar
• Kon E, Filardo G, Delcogliano M, Presti ML, Russo A, Bondi A, et al. Platelet-rich plasma: new clinical application. Injury 2009;40(6):598–603.
   PubMed Web of Science ®Google Scholar
• Filardo G, Kon E, Della Villa S, Vincentelli F, Fornasari PM, Marcacci M. Use of platelet rich plasma for the treatment of refractory jumper’s knee. Int Orthop 2010;34(6):909–915.
   PubMed Web of Science ®Google Scholar
• Brown J, Sivan M. Ultrasound-guided Platelet-rich plasma injection for chronic patellar tendinopathy: a case report. PM&R. Elsevier Inc. 2010;2(10):969–972.
   Web of Science ®Google Scholar
• Scollon-Grieve KL, Malanga GA. Platelet-rich plasma injection for partial patellar tendon tear in a high school athlete: a case presentation. PM&R. Elsevier Inc. 2011;3(4):391–395.
   Web of Science ®Google Scholar
• Gosens T, Den Oudsten BL, Fievez E, Van’T Spijker P, Fievez A. Pain and activity levels before and after platelet-rich plasma injection treatment of patellar tendinopathy: a prospective cohort study and the influence of previous treatments. Int Orthop 2012;36(9):1941–1946.
   PubMed Web of Science ®Google Scholar
• Ferrero G, Fabbro E, Orlandi D, Martini C, Lacelli F, Serafini G, et al. Ultrasound-guided injection of platelet-rich plasma in chronic Achilles and patellar tendinopathy. J Ultrasound. Elsevier Srl. 2012;15(4):260–266.
   PubMedGoogle Scholar
• Vetrano M, Castorina A, Vulpiani MC, Baldini R, Pavan A, Ferretti A. Platelet-rich plasma versus focused shock waves in the treatment of jumper’s knee in athletes. Am J Sports Med 2013;41(4):795–803.
   PubMed Web of Science ®Google Scholar
• Filardo G, Kon E, Di Matteo B, Pelotti P, Di Martino A, Marcacci M. Platelet-rich plasma for the treatment of patellar tendinopathy: clinical and imaging findings at medium-term follow-up. Int Orthop 2013;37(8):1583–1589.
   PubMed Web of Science ®Google Scholar
• Van Ark M, Van Den Akker-Scheek I, Meijer LTB, Zwerver J. An exercise-based physical therapy program for patients with patellar tendinopathy after platelet-rich plasma injection. Phys Ther Sport. Elsevier Ltd. 2013;14(2):124–130.
   PubMed Web of Science ®Google Scholar
• Dragoo JL, Wasterlain AS, Braun HJ, Nead KT. Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial. Am J Sports Med 2014;42(3):610–618.
   PubMed Web of Science ®Google Scholar
• Dallaudière B, Pesquer L, Meyer P, Silvestre A, Perozziello A, Peuchant A, et al. Intratendinous injection of platelet-rich plasma under US guidance to treat tendinopathy: a long-term pilot study. J Vasc Interv Radiol. Elsevier. 2014;25(5):717–723.
   PubMed Web of Science ®Google Scholar
• Charousset C, Zaoui A, Bellaiche L, Bouyer B. Are multiple platelet-rich plasma injections useful for treatment of chronic patellar tendinopathy in athletes? A prospective study. Am J Sports Med 2014;42(4):906–911.
   PubMed Web of Science ®Google Scholar
• Smith J, Sellon JL. Comparing PRP injections with ESWT for athletes with chronic patellar tendinopathy. Clin J Sport Med 2014;24(1):88–89.
   PubMedGoogle Scholar
• Kaux J, Croisier J, Bruyère O, Rodriguez De La Cruz C, Forthomme B, Brabant G, et al. One injection of platelet-rich plasma associated to a submaximal eccentric protocol to treat chronic jumper’s knee. J Sports Med Phys Fitness 2015;55(9):953–961.
   PubMed Web of Science ®Google Scholar
• Kaux JF, Crielaard JM, Bruyère O, Croisier JL, Forthomme B, Le Goff C. One-year follow-up of platelet-rich plasma infiltration to treat chronic proximal patellar tendinopathies. Acta Orthop Belg 2015;81(2):251–256.
   PubMed Web of Science ®Google Scholar
• Kaux JF, Croisier JL, Forthomme B, Le Goff C, Buhler F, Savanier B, et al. Using platelet-rich plasma to treat jumper’s knees: exploring the effect of a second closely-timed infiltration. J Sci Med Sport Sports Med Aust 2014;19(3):200–204.
   Web of Science ®Google Scholar
• Zayni R, Thaunat M, Fayard J-M, Hager J-P, Carrillon Y, Clechet J, et al. Platelet-rich plasma as a treatment for chronic patellar tendinopathy: comparison of a single versus two consecutive injections. Muscles Ligaments Tendons J 2015;5(2):92–98.
   PubMedGoogle Scholar
• De Vos RJ, Weir A, Van Schie HTM, Bierma-Zeinstra SMA, Verhaar JAN, Weinans H, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy. JAMA 2010;303(2):144.
   PubMed Web of Science ®Google Scholar
• Gaweda K, Tarczynska M, Krzyzanowski W, Surgery O. Treatment of Achilles tendinopathy with PRP. Int J Sports Med. 2010;31(8):577–583.
   Google Scholar
• De Jonge S, De Vos RJ, Weir A, Van Schie HTM, Bierma-Zeinstra SMA, Verhaar JAN, et al. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy. Am J Sports Med 2011;39(8):1623–1629.
   PubMed Web of Science ®Google Scholar
• Owens RF, Ginnetti J, Conti SF, Latona C. Clinical and magnetic resonance imaging outcomes following platelet rich plasma injection for chronic midsubstance Achilles tendinopathy. Foot Ankle Int 2011;32(11):1032–1039.
   PubMed Web of Science ®Google Scholar
• Monto RR. Platelet rich plasma treatment for chronic Achilles tendinosis. Foot Ankle Int 2012;33(5):379–385.
   PubMed Web of Science ®Google Scholar
• Deans VM, Miller A, Ramos J, Prospective A. Series of patients with chronic Achilles tendinopathy treated with autologous-conditioned plasma injections combined with exercise and therapeutic ultrasonography. J Foot Ankle Surg. Elsevier Ltd. 2012;51(6):706–710.
   PubMed Web of Science ®Google Scholar
• Mautner K, Colberg RE, Malanga G, Borg-Stein JP, Harmon KG, Dharamsi AS, et al. Outcomes after ultrasound-guided platelet-rich plasma injections for chronic tendinopathy: a multicenter, retrospective review. PM&R. Elsevier Inc. 2013;5(3):169–175.
   Web of Science ®Google Scholar
• Kearney RS, Parsons N, Costa ML. Achilles tendinopathy management: a pilot randomised controlled trial comparing platelet-rich plasma injection with an eccentric loading programme. Bone Joint Res 2013;2(10):227–232.
   PubMed Web of Science ®Google Scholar
• Murawski CD, Smyth N, Newman H, Kennedy JG. A single platelet-rich plasma injection for chronic midsubstance Achilles tendinopathy: a retrospective preliminary analysis. Foot Ankle Spec 2014;7(5):372–376.
   PubMedGoogle Scholar
• Filardo G, Kon E, Di Matteo B, Di Martino A, Tesei G, Pelotti P, et al. Platelet-rich plasma injections for the treatment of refractory Achilles tendinopathy: results at 4 years. Blood Transfus 2014;12(4):533–540.
   PubMed Web of Science ®Google Scholar
• Oloff L, Elmi E, Nelson J, Crain J. Pretreatment and posttreatment correlation of magnetic resonance imaging and clinical assessment. Foot Ankle Spec. 2015;8(6):490–497.
   Google Scholar
• Scioli MW. Platelet-rich plasma injection for proximal plantar fasciitis. Tech Foot Ankle Surg 2011;10(1):7–10.
   Google Scholar
• Aksahin E, Doǧruyol D, YüKsel HY, Hapa O, Doǧan Ö, Çelebi L, et al. The comparison of the eVect of corticosteroids and platelet-rich plasma (PRP) for the treatment of plantar fasciitis. Arch Orthop Trauma Surg 2012;132(6):781–785.
   PubMed Web of Science ®Google Scholar
• Ragab EMS, Othman AMA. Platelets rich plasma for treatment of chronic plantar fasciitis. Arch Orthop Trauma Surg 2012;132(8):1065–1070.
   PubMed Web of Science ®Google Scholar
• Kumar V, Millar T, Murphy PN, Clough T. The treatment of intractable plantar fasciitis with platelet-rich plasma injection. Foot. Elsevier Ltd. 2013;23(2–3):74–77.
   PubMedGoogle Scholar
• Tiwari M, Bhargava R. Platelet rich plasma therapy: a comparative effective therapy with promising results in plantar fasciitis. J Clin Orthop Trauma. Elsevier Ltd. 2013;4(1):31–35.
   PubMedGoogle Scholar
• Martinelli N, Marinozzi A, Carnì S, Trovato U, Bianchi A, Denaro V. Platelet-rich plasma injections for chronic plantar fasciitis. Int Orthop 2013;37(5):839–842.
   PubMed Web of Science ®Google Scholar
• Vijay D, Mandeep D, Chintan H, Prajyot J, Suvin S. A study to compare the efficacy of corticosteroid therapy with platelet-rich plasma therapy in recalcitrant plantar fasciitis: a preliminary report. Foot Ankle Surg Eur Foot Ankle Soc 2014;20(1):10–13.
   PubMed Web of Science ®Google Scholar
• Wilson JJ, Lee KS, Miller AT, Wang S. Platelet-rich plasma for the treatment of chronic plantar fasciopathy in adults: a case series. Foot Ankle Spec 2014;7(1):61–67.
   PubMedGoogle Scholar
• Monto RR. Platelet-rich plasma efficacy versus corticosteroid injection treatment for chronic severe plantar fasciitis. Foot Ankle Int 2014;35(4):313–318.
   PubMed Web of Science ®Google Scholar
• Kim E, Lee JH. Autologous platelet-rich plasma versus dextrose prolotherapy for the treatment of chronic recalcitrant plantar fasciitis. PM&R 2014 Feb 6(2):152–158.
   Web of Science ®Google Scholar
• Jain K, Murphy PN, Clough TM. Platelet rich plasma versus corticosteroid injection for plantar fasciitis: a comparative study. Foot. Elsevier Ltd. 2015;25(4):8–10.
   Google Scholar
• Anitua E, Prado R, Sánchez M, Orive G. Platelet-rich Plasma: preparation and formulation potential of plasma rich in. YOTOR. Elsevier Inc. 2012;22(1):25–32.
   Google Scholar
• Pignatelli P, Pulcinelli FM, Ciatti F, Pesciotti M, Ferroni P, Gazzaniga PP. Effects of storage on in vitro platelet responses: comparison of ACD and Na citrate anticoagulated samples. J Clin Lab Anal. 1995;9(2):138–140.
   Google Scholar
• Lei H, Gui L, Xiao R. The effect of anticoagulants on the quality and biological efficacy of platelet-rich plasma. Clin Biochem Can Soc Clin Chem 2009;42(13–14):1452–1460.
   PubMed Web of Science ®Google Scholar
• Gulliksson H. Platelet storage media. Vox Sang. 2014;107(3);205–212.
   Google Scholar
• Macey M, Azam U, Mccarthy D, Webb L, Chapman ES, Okrongly D, et al. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. Clin Chem. 2002;48:891–9.
   Google Scholar
• Perez AGM, Lana JFSD, Rodrigues AA, Luzo ACM, Belangero WD, Santana MHA. relevant aspects of centrifugation step in the preparation of platelet-rich plasma. ISRN Hematol. 2014;2014:176060.
   Google Scholar
• Arora S, Doda V, Kotwal U, Dogra M. Quantification of platelets and platelet derived growth factors from platelet-rich-plasma (PRP) prepared at different centrifugal force (g) and time. Transfus Apher Sci. 2016;54(1):103–110.
   PubMed Web of Science ®Google Scholar
• Cho JM, Lee YH, Baek RM, Lee SW. Effect of platelet-rich plasma on ultraviolet binduced skin wrinkles in nude mice. J Plast Reconstr Aesthetic Surg Elsevier Ltd 2011;64(2):e31–9. doi: 10.1016/j.bjps.2010.08.014
   PubMed Web of Science ®Google Scholar
• Graziani F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 2006;17(2):212–219.
   PubMed Web of Science ®Google Scholar
• Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone 2004;34(4):665–71.
   Google Scholar
• Moog R, Zeiler T, Heuft HG, Stephan B, Fischer EG, Kretschmer V, et al. Collection of WBC-reduced single-donor PLT concentrates with a new blood cell separator: results of amulticenter study. Transfusion 2003;43(8):1107–1114.
   PubMed Web of Science ®Google Scholar
• Goodnough LT, Kuter D, McCullough J, Brecher ME. Apheresis platelets: emerging issues related to donor platelet count, apheresis platelet yield platelet transfusion dose. J Clin Apher 1998;13(3):114–119.
   PubMed Web of Science ®Google Scholar
• Keklik M, Eser B, Kaynar L, Solmaz M, Ozturk A, Yay M, et al. Comparison of double dose plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC and Trima Accel cell separators. Transfus Apher Sci. Elsevier Ltd. 2014;51(2):193–196.
   PubMed Web of Science ®Google Scholar
• Altuntas F, Sari I, Kocyigit I, Kaynar L, Hacioglu S, Ozturk A, et al. Comparison of plateletpheresis on the Fenwal Amicus and Fresenius Com. TEC cell separators. Transfus Med Hemother 2008;35(September):368–373.
   PubMedGoogle Scholar
• Scott A, Km K, Cr R, Jl C, Duronio V. What do we mean by the term “inflammation”? A contemporary basic science update for sports medicine. Br J Sports Med 2004;38(3):372–380.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chen S, Chang P, Bao N, Yang C, Ti Y, et al. Harmful effects of leukocyte- rich platelet-rich plasma on rabbit tendon stem cells in vitro. Am J Sports Med 2016;44(8):1941–51.
   PubMed Web of Science ®Google Scholar
• McCarrel TM, Minas T, Fortier L. Optimization of leukocyte concentration in plateletrich plasma for the treatment of tendinopathy. J Bone Joint Surg Am 2012;94(19):e143(1–8).
   PubMedGoogle Scholar
• Dragoo JL, Braun HJ, Durham JL, Ridley B, Odegaard JI, Luong R, et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy Rabbit Tendons. Am J Sports Med 2012;40:1274–1281.
   PubMed Web of Science ®Google Scholar
• Pizza FX, McLoughlin TJ, McGregor SJ, Calomeni EP, Gunning WT. Neutrophils injure cultured skeletal myotubes. Am J Physiol Cell Physiol 2001;281(1):C335–41.
   PubMed Web of Science ®Google Scholar
• Grageda E. Platelet-rich plasma and bone graft materials: a review and a standardized research protocol. Implant Dent 2004;13:301–309.
   PubMedGoogle Scholar
• Marlovits S, Mousavi M, Gäbler C, Erdös J. A new simplified technique for producing platelet-rich plasma: a short technical note. Eur Spine J. 2004 Oct;13Suppl 1:S102–6.
   Google Scholar
• Dhurat R. Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg. 2014;7(4):189–197.
   Google Scholar
• Weibrich G, Kleis W, Kunz-Kostomanolakis M, Loos A, Wagner W. Correlation of platelet concentration in platelet-rich plasma to the extraction method, age, sex, and platelet count of the donor. Int J Oral Maxillo Fac Implant 2001;16(5):693–699.
   PubMed Web of Science ®Google Scholar
• Woodell-May J, Ridderman D, Swift M, Higgins J. Producing accurate platelet counts for platelet rich plasma: validation of a hematology analyzer and preparation techniques for counting. J Craniofac Surg 2005;16:749–759.
   PubMed Web of Science ®Google Scholar
• Martineau I, Lacoste E, Gagnon G. Effects of calcium and thrombin on growth factor release from platelet concentrates: kinetics and regulation of endothelial cell proliferation. Biomaterials 2004;25(18):4489–4502.
   PubMed Web of Science ®Google Scholar
• Bausset O, Magalon J, Giraudo L, Louis M, Serratrice N, Frere C, et al. Impact of local anaesthetics and needle calibres used for painless PRP injections on platelet functionality. Muscles Ligaments Tendons J. 2014;4(1):18–23.
   Google Scholar
• Carofino B, Chowaniec DM, Mccarthy MB, Bradley JP, Delaronde S, Beitzel K, et al. Corticosteroids and local anesthetics decrease positive effects of platelet-rich plasma: an in vitro study on human tendon cells. YJARS. Elsevier Inc. 2012;28(5):711–719.
   PubMed Web of Science ®Google Scholar
• Loftus ML, Endo Y, Adler RS. Retrospective analysis of postinjection ultrasound imaging after platelet-rich plasma or autologous blood: observational review of anatomic distribution of injected material. AJR Am J Roentgenol 2012 Oct 199(4):W501–W505.
   PubMed Web of Science ®Google Scholar
• Libertiaux V, Sancerne A, Le Goff C, Crielaard JM, Kaux JF. Are there biologic factors of good prognosis after a platelet rich plasma (PRP) injection for tendinopathies. J Exercise Sports Orthopedics 2016;3(2):1–4.
   Google Scholar